[1]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[2]
|
Hitoshi, K., Takashi, I., Kohei, A., Isobe, Y., Miyashiro, I., Oda, I., et al. (2018) Five-Year Survival Analysis of Surgically Resected Gastric Cancer Cases in Japan: A Retrospective Analysis of More Than 100,000 Patients from the Nationwide Registry of the Japanese Gastric Cancer Association (2001-2007). Gastric Cancer, 21, 144-154.
https://doi.org/10.1007/s10120-017-0716-7
|
[3]
|
Sumiyama, K. (2017) Past and Current Trends in Endoscopic Di-agnosis for Early Stage Gastric Cancer in Japan. Gastric Cancer, 2, 20-27. https://doi.org/10.1007/s10120-016-0659-4
|
[4]
|
Fariborz, M., Farahnaz, J., Yaghoub, R. and Tolou, H. (2014) Screening of Precancerous Gastric Lesions by Serum Pepsinogen, Gastrin-17, Anti-Helicobacter Pylori and Anti-CagA Antibodies in Dyspeptic Patients over 50 Years Old in Guilan Province, North of Iran. Asian Pacific Journal of Cancer Prevention, 15, 7635-7638.
https://doi.org/10.7314/APJCP.2014.15.18.7635
|
[5]
|
朱春平, 赵建业, 申晓军, 钱维, 马颖才, 张硕, 等. 血清胃泌素-17联合胃蛋白酶原检测对胃癌诊断价值的多中心临床研究[J]. 中华消化内镜杂志, 2017, 34(1): 19-23.
|
[6]
|
李梦颖, 张德庆, 陆绚, 陈卫昌. 两种血清学方法在胃癌及其癌前状态筛查中的价值[J]. 中华内科杂志, 2018, 57(12): 907-911.
|
[7]
|
Bang, C.S., Lee, J.J. and Baik, G.H. (2019) Diagnostic Performance of Serum Pepsin-ogen Assay for the Prediction of Atrophic Gastritis and Gastric Neoplasms: Protocol for a Systematic Review and Me-ta-Analysis. Medicine, 98, Article ID: e14240. https://doi.org/10.1097/MD.0000000000014240
|
[8]
|
Weiwei, Z., Shuxiang, Z., Lei, Y., Wei, W., Gao, J., Guo, N., et al. (2020) Serum MiR-101-3p Combined with Pepsinogen Contrib-utes to the Early Diagnosis of Gastric Cancer. BMC Medical Genetics, 21, Article No. 28.
https://doi.org/10.1186/s12881-020-0967-8
|
[9]
|
Kazumasa, M. (2006) Gastric Cancer Screening Using the Serum Pepsinogen Test Method. Gastric Cancer, 9, 245-253.
https://doi.org/10.1007/s10120-006-0397-0
|
[10]
|
Osumi, H., Fujisaki, J., Suganuma, T., Horiuchi, Y., Omae, M., Yoshio, T., et al. (2017) A Significant Increase in the Pepsinogen I/II Ratio Is a Reliable Biomarker for Successful Heli-cobacter Pylori Eradication. PLOS ONE, 12, Article ID: e0183980. https://doi.org/10.1371/journal.pone.0183980
|
[11]
|
Kim, N. and Jung, H.C. (2010) The Role of Serum Pepsinogen in the Detection of Gastric Cancer. Gut Liver, 4, 307-319. https://doi.org/10.5009/gnl.2010.4.3.307
|
[12]
|
Shulkes, A. and Baldwin, G. (2001) Biology and Pathology of Non-Amidated Gastrins. Scandinavian Journal of Clinical and La-boratory Investigation, 234, 123-128. https://doi.org/10.1080/713783693
|
[13]
|
Sun, L., Tu, H., Liu, J., Gong, Y., Xu, Q., Jing, J., et al. (2014) A Comprehensive Evaluation of Fasting Serum Gastrin-17 as a Predictor of Diseased Stomach in Chinese Population. Scandinavian Journal of Gastroenterology, 49, 1164-1172. https://doi.org/10.3109/00365521.2014.950693
|
[14]
|
陈莫耶, 徐倩, 孙丽萍, 孙明军. 血清胃泌素17水平与胃癌及癌前疾病的相关性研究[J]. 胃肠病学和肝病学杂志, 2015, 24(2): 161-165.
|
[15]
|
Li, Y., Zhao, Y., Li, Y., Zhang, X., Li, C., Long, N., et al. (2021) Gastrin-17 Induces Gastric Cancer Cell Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Signaling Pathway. Journal of Physiology and Biochemistry, 77, 93-104. https://doi.org/10.1007/s13105-020-00780-y
|
[16]
|
Hooi, J., Lai, W.Y., Ng, W.K., Suen, M.M.Y., Underwood, F.E., Tanyingoh, D., et al. (2017) Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology, 153, 420-429.
https://doi.org/10.1053/j.gastro.2017.04.022
|
[17]
|
Guo, Y., Zhang, Y., Gerhard, M., Gao, J.J., Mejias-Luque, R., Zhang, L., et al. (2020) Effect of Helicobacter Pylori on Gastrointestinal Microbiota: A Population-Based Study in Linqu, a High-Risk Area of Gastric Cancer. Gut, 69, 1598-1607.
https://doi.org/10.1136/gutjnl-2019-319696
|
[18]
|
Zhang, L., Ren, J., Pan, K., Ma, J., Li, J., Shen, L., et al. (2010) Detection of Gastric Carcinoma-Associated MG7-Ag by Serum Immuno-PCR Assay in a High-Risk Chinese Population, with Implication for Screening. International Journal of Cancer, 126, 469-473. https://doi.org/10.1002/ijc.24739
|
[19]
|
Zongyue, Z., Sheng, F., Ping, H., Zhao, L., Zhang, H., Tang, X., et al. (2014) The Diagnostic Value of Monoclonal Gastric Cancer 7 Antigen: A Systematic Review with Meta-Analysis. Clinical and Experimental Medicine, 14, 337-343.
https://doi.org/10.1007/s10238-013-0246-5
|
[20]
|
杨枫, 王晓玲, 邬虹娇, 孙晓兰, 陈敏. 血清肿瘤标志物水平与胃癌的关系研究[J]. 中国肿瘤临床与康复, 2022, 29(3): 265-268.
|
[21]
|
韩梅, 连俊, 马明杰, 喇琴, 张辉. 血清胃蛋白酶原与肿瘤标志物CEA、CA199、CA242、CA724联合检测对胃癌诊断的价值分析[J]. 河北医药, 2019, 41(23): 3574-3577.
|
[22]
|
刘忆华, 成善泉, 漆晴, 彭清烨, 郑安斌. CEA、AFP和CA242在胃癌病理诊断及预后评估中的作用[J]. 河北医药, 2017, 39(9): 1335-1337.
|
[23]
|
孙会, 祝丽晶, 王正前. 血清肿瘤标志物联合检测对胃癌的诊断价值[J]. 中国当代医药, 2020, 27(21): 4-7+封3.
|
[24]
|
杨莉, 李晓南, 杨晓雪. 血清肿瘤标志物CEA、CA19-9及CA724联合检测在胃癌诊断中的价值分析[J]. 临床和实验医学杂志, 2020, 19(4): 387-391.
|
[25]
|
Feng, F., Tian, Y., Xu, G., Liu, Z., Liu, S., Zheng, G., et al. (2017) Diagnostic and Prognostic Value of, C.E.A., CA19-9, AFP and CA125 for Early Gastric Cancer. BMC Cancer, 17, Article No. 737.
https://doi.org/10.1186/s12885-017-3738-y
|
[26]
|
Hideaki, S., Tamaki, N., Manabu, O., Koji, O. and Yutaka, T. (2014) Clinical Significance of Serum Tumor Markers for Gastric Cancer: A Systematic Review of Literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer, 17, 26-33. https://doi.org/10.1007/s10120-013-0259-5
|
[27]
|
蔡晓娟, 王堃, 喻晶. 异常凝血酶原联合CEA、CA72-4和CA199在胃癌诊治中的价值[J]. 肿瘤防治研究, 2018, 45(6): 395-399.
|
[28]
|
Song, X.H., Liu, K., Yang, S.J., Zhang, W.-H., Chen, X.-L., Zhao, L.-Y., et al. (2020) Prognostic Value of Changes in Preoperative and Postoperative Serum CA19-9 Levels in Gastric Cancer. Frontiers in Oncology, 10, Article No. 1432.
https://doi.org/10.3389/fonc.2020.01432
|
[29]
|
李湘英. 肿瘤标志物联合检测在消化道恶性肿瘤中的应用[J]. 国际检验医学杂志, 2012, 33(19): 2415-2417.
|
[30]
|
杨剑, 万成乐, 金雷. CA72-4、CA19-9、CA125、CA50医学参考值范围及其对胃癌早期诊断价值的研究[J]. 分子诊断与治疗杂志, 2021, 13(7): 1150-1153.
|
[31]
|
廖专, 孙涛, 吴浩, 杨帆, 邹文斌. 中国早期胃癌筛查及内镜诊治共识意见(2014年, 长沙) [J]. 中华消化杂志, 2014, 34(7): 433-448.
|
[32]
|
Miki, K. (2011) Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter Pylori IgG Antibody and Serum Pepsinogen Levels—“ABC Method”. Proceedings of the Japan Academy, Series B, Physical and Biological Sciences, 87, 405-14. https://doi.org/10.2183/pjab.87.405
|
[33]
|
冯慧. 上消化道早癌筛查、诊断及其相关技术的探索性研究[D]: [博士学位论文]. 合肥: 安徽医科大学, 2016.
|
[34]
|
周玉梅. 血清胃蛋白酶原比值联合胃泌素-17在早期胃癌诊断中的临床价值[J]. 临床医药文献电子杂志, 2019, 6(90): 132+134.
|
[35]
|
杜奕奇, 蔡全才, 廖专, 方军, 朱春平, 等. 中国早期胃癌筛查流程专家共识意见(草案) (2017年, 上海) [J]. 胃肠病学, 2018, 23(2): 92-97.
|
[36]
|
高福利, 钱建清, 徐晓丹, 王卫军, 刘罗杰. 新型胃癌评分系统在早期胃癌筛查中的应用[J]. 中国实用医刊, 2020, 47(16): 6-9.
|
[37]
|
倪栋琼, 吕宾, 包海标, 金海峰, 赵晶, 徐毅, 等. 不同血清学危险分层方法在人群早期胃癌筛查中的比较研究[J]. 中华内科杂志, 2019, 58(4): 294-300.
|
[38]
|
文采, 肖明娜, 朴善英. PG、MG7-Ag联合G-17检测对胃癌前病变、胃癌的诊断及鉴别诊断[J]. 分子诊断与治疗杂志, 2020, 12(11): 1488-1492.
|
[39]
|
孟培, 龙拥军, 戴平, 王坤. 联合检测血清抗HpAb、胃泌素-17和MG7-Ag对胃癌诊断的临床意义[J]. 标记免疫分析与临床, 2019, 26(2): 216-219.
|
[40]
|
Lin, Z., Bian, H., Chen, C., Chen, W. and Li, Q. (2021) Application of Serum Pepsinogen and Carbohydrate Antigen 72-4 (CA72-4) Combined with Gastrin-17 (G-17) Detec-tion in the Screening, Diagnosis, and Evaluation of Early Gastric Cancer. Journal of Gastrointestinal Oncology, 12, 1042-1048. https://doi.org/10.21037/jgo-21-254
|
[41]
|
庄伟, 计钰亮, 朱婷婷. 早期胃癌胃镜筛查中联合应用血清PG、G-17、CA72-4及Hp检测的价值研究[J]. 浙江医学, 2020, 42(14): 1529-1532.
|
[42]
|
王晓阳, 谢爱敏, 郎少磊. CA72-4、CA19-9、CEA在胃癌诊断及预后评价中的应用价值[J]. 哈尔滨医药, 2020, 40(6): 555-557.
|
[43]
|
刘彦合, 宋杰峰, 李慧, 叶晓谊, 曾祥勇. 血清肿瘤标志物CEA、CA19-9、CA242及CA724联合检测在胃癌诊断中的价值分析[J]. 现代消化及介入诊疗, 2019, 24(4): 416-420.
|